A Comparative Study of Improvement of Hyperkalemia by Sodium Zirconium Cyclosilicate Hydrate and Polystyrene Sulfonate Calcium in Chronic Hemodialysis Patients (Multicenter collaborative study)
Not Applicable
Recruiting
- Conditions
- End-stage renal disease requiring maintenance hemodialysis
- Registration Number
- JPRN-UMIN000042090
- Lead Sponsor
- Kanazawa Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients with an allergy to sodium zirconium cyclosilicate hydrate or polystyrene sulfonate calcium 2. Patients with intestinal stenosis or severe constipation 3. Patients who are pregnant or breastfeeding 4. Patients who participated in another clinical trial (study) less than three months prior to commencing the test drug Grounds for setting the exclusion criteria: 1 - 3 are in consideration of safety and 4 is in consideration of the effect on the efficacy evaluation and safety
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method